GSK lifts long-term sales targets on new drug pipeline
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
Jefferies Sticks to Its Sell Rating for Novo Nordisk (0QIU)
In a report released today, Peter Welford from Jefferies maintained a Sell rating on Novo Nordisk (0QIU – Research Report), with a price target ...
Analgesics Market Expected To Reach USD 131.29 Billion by 2032,Growing at CAGR of 4.6% | Johnson & Johnson, Pfizer Inc., GlaxoSmithKline
Exploring Analgesics as a Key Painkiller Types & Their Role in Pain ReliefUnited States, New York, Feb. 04, 2025 (GLOBE ...
GSK Announces £2 Billion Share Buyback as Profit Beats Estimates
GSK Plc announced a share buyback of £2 billion as it saw better than expected profit in the fourth quarter. The share ...
GSK beats Q4 earnings estimates, lifts 2031 sales target
GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...
GSK Expects Further Profit Growth After Beating Market Views
The pharmaceutical giant targets an increase in core operating profit of between 6% and 8% in 2025, after cancer treatments ...
GSK Sales, Core Earnings Expected to Fall -- Earnings Preview
CORE EARNINGS PER SHARE FORECAST: Fourth-quarter core earnings per share is expected to fall to 20.6 pounds from 28.9 pounds the year earlier, according to Visible Alpha. Shares in GSK are 3.6% up ...
ophthalmologyadvisor13h
Rhinoconjunctivitis in Children With Asthma May Not Always Be Allergy Driven
Phenotyping children with asthma based on rhinoconjunctivitis symptoms shows that rhinoconjunctivitis may not always be allergy driven.
Indiatimes11h
GSK Pharma - GlaxoSmithKline Pharmaceuticals Share Price
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...